Why Is DexCom (DXCM) In Focus After Its G7 Trial Reached NEJM?

DexCom (NasdaqGS:DXCM) reported that results from the CONNECT randomized controlled trial of its G7 CGM were published in The ...
HealthDay on MSN

CGM beneficial for adults with type 2 diabetes not on insulin

Continuous glucose monitoring (CGM) leads to a greater reduction in glycated hemoglobin (HbA1c) levels than routine care for ...
Managed Healthcare Executive

Jessica Castle, M.D., discusses CGM’s A1C impact in non-insulin type 2 diabetes

Adults with type 2 diabetes who don't use insulin lowered their A1C by 0.9 percentage points more with a continuous glucose monitor (CGM) than with routine care over 26 weeks, according to results ...

Diabeloop announces the completion of its balance sheet restructuring and looks ahead to the next phase of its development

DBLG2 brings Diabeloop’s automated insulin delivery algorithm directly to a compatible smartphone. Connected to a continuous glucose monitor and an insulin pump, the AI driven algorithm analyzes ...

Global Medical Devices Market Size, Share, and Growth Forecast to 2031 | Aging Populations Push the Global Medical Devices Market Toward $818 Billion

The global medical devices market is projected to grow from $580.79 billion in 2026 to $817.78 billion by 2031, a new report finds, as chronic disease and hospital investment rise, though lengthy ...

Abbott Q3: Nutrition Spin-Out, Narrowed Guidance Rocks Stock; For Now, At Least

Abbott Laboratories remains a "Buy," anticipating double-digit growth, despite near-term volatility and underwhelming 2026 ...